Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients
... NBI colonoscopy. Protruding lesions and flat mucosa were observed by NBI magnifying colonoscopy at a ... surrounding mucosa. Otherwise, indistinctive flat mucosa was assessed. The surface structure was ... in protrusions (2/20 sites, 10%) than in flat mucosa (3/276 sites, 1.1%, P = .038; however, correction ...New therapeutic targets in the treatment of ulcerative colitis
... and TNF-alpha were over expressed in the colonic mucosa of patients with ulcerative colitis. The over ... matrix, and subsequently damages the colonic mucosa and causes ulceration and inflammatory changes in ... cells to produce more MMP-1, aggravating the mucosa damage. Meanwhile, MMP-1 promoted secretion of ...DFMO may affect Barrett's esophagus
... synthesis called ornithine decarboxylase (ODC). "ODC activity in Barrett's mucosa has been shown to be significantly higher in Barrett's than in normal adjacent mucosa from the same patients," Sinicrope said. "Since DFMO inhibits polyamine ...JCI online early table of contents: Feb. 7, 2008
... is not well understood. By studying explant cultures of human colonic mucosa (the lining of the large intestine), Anne Jarry and colleague,s at INSERM ... colonic mucosa. Depletion of IL-10 in explant cultures of human colonic mucosa led to increased expression of pro-inflammatory factors such as IFN-gamma, ...BDSI files FDA NDA for BEMA Fentanyl
... Given the sensitivity many cancer patients have associated with their oral mucosa (i.e., cheeks and gums), we took extra care to examine what effects our dosage form (that adheres to the oral mucosa before dissolving) might have in this area. We are very pleased to report ...Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
... chemotherapy and radiotherapy, is estimated to be in excess of $5 billion world-wide. MuGard forms a protective coating over the oral mucosa when swirled gently around the mouth. In a comparison of cancer patients receiving standard mucositis care with those patients receiving MuGard, the ...Arpida Announces Promising Results of "First-In-Man" Studies With AR-709
... the determination of drug concentrations in lung compartments. The results showed that AR-709 achieves high concentrations in bronchial mucosa (BM), epithelial lining fluid (ELF) and alveolar macrophages (AM), the three key compartments of the lungs where pathogens can reside and replicate. ...Standard 3-Way Foley Catheters
Description:... latex Foleys, Rochester Medical's all-silicone catheters will not leach chemicals or water-soluble proteins that can irritate the urethral mucosa and lead to stricture formation. The non-stick surface of silicone makes it highly resistant to ....Standard 2-Way Foley Catheters
Description:... latex Foleys, Rochester Medical's all-silicone catheters will not leach chemicals or water-soluble proteins that can irritate the urethral mucosa and lead to stricture formation. The non-stick surface of silicone makes it highly resistant to ....Estradiol, Ultra-Sensitive RIA Test
Description:... include stimulation of linear bone growth, acceleration of epiphyseal closure, stimulation of mammary development, and maturation of the vaginal mucosa and uterine endometrium. Estradiol may also contribute to the development of the female (gynoid) body habitus, and may have metabolic and behavioral ...UC Davis researchers discover how HIV turns food-poisoning into lethal infection
... HIV. In a 2006 study, she found that HIV continued to replicate in the gut mucosa and suppress immune function in patients being treated with antiretroviral ... between an individuals immune system and HIV is happening in the gut mucosa where there is massive destruction of immune cells, Dandekar said. ...Skin-like tissue developed from human embryonic stem cells
... Tufts have harnessed the pluripotency of human embryonic stem cells (hESC) to generate complex, multilayer tissues that mimic human skin and the oral mucosa (the moist tissue that lines the inside of the mouth). The proof-of-concept study is published online in advance of print in Tissue Engineering Part ...Nanotechnology holds promise for STD drug delivery
... found that the particles, loaded with the drug agent, moved effectively in two important ways, penetrating to reach cells below the surface of the mucosa and distributing throughout the vaginal, cervical, and uterine regions. Furthermore, the siRNAs stayed in the tissues for at least a week and ...Human Microbiome Project awards funds for technology development, data analysis and ethical research
... Vincent Young, M.D., Ph.D., University of Michigan, Ann Arbor; $1.3 million (3 years); Cultivation and Characterization of the Microaerobes from the mucosa of the Gastrointestinal Tract. Kun Zhang, Ph.D. and Yu-Hwa Lo, Ph.D., University of California, San Diego; $1.8 million (3 years); An Integrated ...Breakthrough optical technology to assess colon cancer risk, accuracy
... was elevated 75.3 percent above control levels (comparable region from patients with no adenomas) at the adenoma site and persisted in the uninvolved mucosa (microscopically normal) area. Moreover, tissue sites located within 10 and 30 centimeters away from an adenoma also manifested a highly ...Change in gene may be underlying molecular defect in some colorectal cancers
... in the tumor, adjacent mucosa, and nonadjacent mucosa of 95 colorectal cancer patients and in the colon mucosa of 33 subjects without cancer. MGMT promoter ... method of detection, and normal-appearing colon mucosa up to 10 cm away from the tumor had detectable ...MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
... chemotherapy and radiation therapy, is estimated to be in excess of $5 billion world-wide. MuGard forms a protective coating over the oral mucosa when swirled gently around the mouth. In a comparison of cancer patients receiving standard mucositis care with those patients receiving MuGard, the ...Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
... for the treatment of oral mucositis is estimated to be in excess of $1 billion world-wide. MuGard forms a protective coating over the oral mucosa when swirled gently around the mouth. In a comparison of cancer patients receiving standard mucositis care with those patients receiving MuGard, the ...Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm
... for the treatment of oral mucositis is estimated to be in excess of $1 billion world-wide. MuGard forms a protective coating over the oral mucosa when swirled gently around the mouth. In a comparison of cancer patients receiving standard mucositis care with those patients receiving MuGard, the ...Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
... About MuGard(TM): MuGard is a ready-to-use mucoadhesive oral wound rinse. The mucoadhesive formulation forms a protective coating over the oral mucosa when washed around the mouth. In a comparison of cancer patients receiving standard mucositis care with those patients using MuGard, the incidence ...